Cargando…

Bone Metastases Treatment by Sm-153 Oxabifore in Combination with Monoclonal Antibody Denosumab (Xgeva)

Detalles Bibliográficos
Autores principales: Joob, Beuy, Wiwanitkit, Viroj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262883/
https://www.ncbi.nlm.nih.gov/pubmed/25538496
http://dx.doi.org/10.4103/1450-1147.144825
_version_ 1782348477315940352
author Joob, Beuy
Wiwanitkit, Viroj
author_facet Joob, Beuy
Wiwanitkit, Viroj
author_sort Joob, Beuy
collection PubMed
description
format Online
Article
Text
id pubmed-4262883
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-42628832014-12-23 Bone Metastases Treatment by Sm-153 Oxabifore in Combination with Monoclonal Antibody Denosumab (Xgeva) Joob, Beuy Wiwanitkit, Viroj World J Nucl Med Letter to Editor Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC4262883/ /pubmed/25538496 http://dx.doi.org/10.4103/1450-1147.144825 Text en Copyright: © World Journal of Nuclear Medicine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to Editor
Joob, Beuy
Wiwanitkit, Viroj
Bone Metastases Treatment by Sm-153 Oxabifore in Combination with Monoclonal Antibody Denosumab (Xgeva)
title Bone Metastases Treatment by Sm-153 Oxabifore in Combination with Monoclonal Antibody Denosumab (Xgeva)
title_full Bone Metastases Treatment by Sm-153 Oxabifore in Combination with Monoclonal Antibody Denosumab (Xgeva)
title_fullStr Bone Metastases Treatment by Sm-153 Oxabifore in Combination with Monoclonal Antibody Denosumab (Xgeva)
title_full_unstemmed Bone Metastases Treatment by Sm-153 Oxabifore in Combination with Monoclonal Antibody Denosumab (Xgeva)
title_short Bone Metastases Treatment by Sm-153 Oxabifore in Combination with Monoclonal Antibody Denosumab (Xgeva)
title_sort bone metastases treatment by sm-153 oxabifore in combination with monoclonal antibody denosumab (xgeva)
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262883/
https://www.ncbi.nlm.nih.gov/pubmed/25538496
http://dx.doi.org/10.4103/1450-1147.144825
work_keys_str_mv AT joobbeuy bonemetastasestreatmentbysm153oxabiforeincombinationwithmonoclonalantibodydenosumabxgeva
AT wiwanitkitviroj bonemetastasestreatmentbysm153oxabiforeincombinationwithmonoclonalantibodydenosumabxgeva